Valproate sodium

Seizure Management

Valproate sodium is used to treat several types of seizure disorders, either alone or in combination with other medications. It is specifically indicated for:

• Complex partial seizures: These occur by themselves or in association with other types of seizures.
• Absence seizures: It is used for both simple and complex absence seizures, which are brief lapses in consciousness.

Bipolar Disorder

This medication is used to treat the manic phase of bipolar disorder, also known as manic-depressive illness. During these episodes, individuals may experience periods of extreme excitement, rapid speech, or irritability.

Migraine Prevention

Valproate sodium is prescribed to reduce the frequency of migraine headaches. It is intended for prevention and is not effective for treating a migraine headache that is already in progress.

Administration

While often taken orally, valproate sodium may be administered as an intravenous injection in a clinical setting when a patient is temporarily unable to take the medication by mouth.

Mechanism of Action

The exact way valproate sodium works in the body is not fully understood. However, researchers believe it primarily works by increasing the amount of a specific chemical in the brain called gamma-aminobutyric acid (GABA).

The Role of GABA

GABA is an inhibitory neurotransmitter, which means its job is to calm or slow down nerve activity in the central nervous system. By increasing GABA levels, valproate sodium helps to:

• Reduce electrical activity: It helps prevent the rapid and excessive firing of neurons that leads to seizures.
• Stabilize mood: In conditions like bipolar disorder, it helps regulate brain signals to manage episodes of mania.
• Prevent migraines: It helps reduce the brain's sensitivity to triggers that can cause migraine headaches.

By influencing these chemical messengers, the medication helps restore a more normal balance of electrical and chemical signals in the brain.

Common Side Effects

Valproate sodium may cause several common side effects. Many of these are mild and may go away as your body adjusts to the medication. Common side effects include:

• Nausea, vomiting, or stomach pain
• Diarrhea or constipation
• Dizziness or drowsiness
• Headache
• Tremors (shaking) or coordination problems
• Changes in appetite or weight gain
• Temporary hair loss
• Blurred or double vision
• Unusual taste in the mouth

Serious Side Effects

Seek medical attention immediately if you experience any of the following serious side effects:

• Liver damage: Signs include yellowing of the skin or eyes (jaundice), dark urine, loss of appetite, or pain on the right side of the stomach.
• Pancreatitis: Severe stomach pain that spreads to the back, along with nausea and vomiting.
• Mental health changes: New or worsening depression, anxiety, panic attacks, or thoughts about suicide or self-harm.
• High ammonia levels: Unexplained confusion, lack of energy, or vomiting.
• Blood issues: Easy bruising, unusual bleeding, or fever and sore throat.
• Severe skin reactions: Rash, hives, peeling skin, or painful sores in the mouth or around the eyes.
• Low body temperature: An unexpected drop in body temperature (hypothermia).

Boxed Warnings

Valproate sodium has several boxed warnings due to the potential for severe or fatal complications. These include:

• Hepatotoxicity: Severe or fatal liver failure has occurred, usually within the first six months of treatment. The risk is highest in children under two years of age, especially those with mitochondrial disorders, multiple seizure medications, or metabolic conditions.
• Teratogenicity: This medication can cause major birth defects, such as neural tube defects (spina bifida), and is associated with decreased IQ and neurodevelopmental disorders in children exposed during pregnancy. It should not be used for migraine prevention during pregnancy and should only be used for epilepsy or bipolar disorder if other treatments are ineffective.
• Pancreatitis: Cases of life-threatening inflammation of the pancreas have been reported in both children and adults. This can occur shortly after starting the medication or after several years of use.

Contraindications

Valproate sodium is contraindicated in certain populations, including:

• Individuals with known liver disease or significant liver dysfunction.
• People with urea cycle disorders, as the medication can cause dangerous levels of ammonia to build up in the blood.
• Patients with mitochondrial disorders caused by mutations in the POLG gene.
• Pregnant individuals when used for the prevention of migraine headaches.

Other Serious Precautions

Suicidal Thoughts and Behavior

Like other antiepileptic drugs, valproate sodium may increase the risk of suicidal thoughts or behaviors. Monitoring for new or worsening depression, anxiety, or changes in mood is necessary.

Hyperammonemia

High ammonia levels in the blood can occur even if liver function tests appear normal. This risk is increased when valproate is used in combination with topiramate. Symptoms may include unexplained lethargy or changes in mental status.

Bleeding and Blood Disorders

Valproate may cause a decrease in platelet counts (thrombocytopenia), which can lead to easy bruising or bleeding. It may also affect blood clotting factors. Blood tests are typically performed before starting treatment and periodically thereafter to monitor blood cell counts.

Drug Interactions

Significant interactions can occur with other medications. For example, certain carbapenem antibiotics can drastically lower the concentration of valproate in the blood, potentially leading to a loss of seizure control.

Pregnancy Risks

Valproate sodium can cause serious harm to an unborn baby if taken during pregnancy. Exposure in the womb increases the risk of major birth defects, such as neural tube defects like spina bifida, as well as heart and limb malformations. These issues often develop early in the first trimester.

Research also indicates that children exposed to valproate during pregnancy may have a higher risk of lower IQ scores and developmental delays affecting language and memory. Due to these risks, the medication is generally not used for migraine prevention during pregnancy. For conditions like epilepsy or bipolar disorder, it is typically reserved for situations where other treatments are not effective.

Planning and Prevention

• Contraception: Healthcare providers recommend that individuals of childbearing age use effective birth control while taking valproate sodium.
• Medical Consultation: If you become pregnant or plan to become pregnant, speak with your doctor immediately. It is dangerous to stop taking this medication abruptly without medical supervision, as uncontrolled seizures can harm both the parent and the baby.

Breastfeeding

Valproate sodium passes into breast milk. While it is often considered compatible with breastfeeding, it is important to consult a healthcare provider. Infants should be monitored for signs of side effects, such as unusual bruising, bleeding, or yellowing of the skin and eyes.

Injectable Form

Valproate sodium is available as an intravenous (IV) solution for injection. This form is typically administered by a healthcare professional in a clinical setting when oral medication is not an option.

Oral Forms

Valproate and its related compounds, such as valproic acid and divalproex sodium, are available in several oral formulations:

• Tablets: These include delayed-release and extended-release versions designed to release the medication at different rates.
• Capsules: Available as standard capsules and delayed-release sprinkle capsules, which may be opened and sprinkled onto food for patients who have difficulty swallowing.
• Oral Liquid: This is commonly available as a syrup.

The specific form and strength prescribed depend on the condition being treated, the patient's age, and how they respond to the medication.

FDA Approval and Indications

Valproate sodium is approved by the U.S. Food and Drug Administration (FDA) for several clinical uses. It is indicated for the treatment of complex partial seizures and simple and complex absence seizures, either alone or in combination with other medications. It is also approved for the treatment of manic episodes associated with bipolar disorder and for the prophylaxis of migraine headaches.

Boxed Warnings

The FDA has required boxed warnings for valproate sodium due to the risk of severe and potentially fatal adverse reactions:

• Hepatotoxicity: Serious or fatal liver damage has occurred, typically within the first six months of treatment. The risk is highest in children under two years of age, especially those on multiple anticonvulsants or with metabolic disorders.
• Fetal Risk: Valproate can cause major birth defects, such as neural tube defects, and decreased IQ scores in children exposed in utero. Because of these risks, it should not be used for migraine prevention in pregnant women and should only be used for other conditions in women of childbearing age if alternative treatments are ineffective.
• Pancreatitis: Life-threatening cases of pancreatitis have been reported in both children and adults. This can occur shortly after starting the drug or after several years of use.

Safety Communications

The FDA has issued safety communications regarding the risk of suicidal thoughts or behavior associated with the use of antiepileptic drugs, including valproate sodium. Patients should be monitored for any changes in mood or behavior. Additionally, the FDA has strengthened warnings regarding the use of valproate in women of childbearing age, emphasizing that the medication should only be used when other options have failed due to the high risk of developmental issues in offspring.

Risks of Sudden Discontinuation

It is critical not to stop taking valproate sodium without first consulting a healthcare professional. Abruptly ending treatment can cause seizures to return or become more frequent and severe. In some cases, stopping the medication suddenly can trigger status epilepticus, a condition where seizures do not stop or occur so frequently that the person does not recover between them. This is a medical emergency that can lead to brain damage or death.

Safe Tapering Process

If you and your doctor decide to discontinue valproate sodium, the dose is typically reduced gradually. A slow tapering process helps the body adjust and minimizes the risk of withdrawal-related seizures. Your healthcare provider will determine the safest schedule for decreasing your dosage based on your medical history and the condition being treated.

When to Contact a Doctor

If you miss a dose or are concerned about side effects, contact your doctor immediately rather than stopping the medication on your own. They can provide guidance on how to manage side effects while maintaining seizure control or mood stability.